The classic concept of viral infection involves an initial interaction between determinants on the surface of a virus and cellular receptor binding sites of appropriate viral specificity, followed by stages of penetration, un coating , and replication of the viral genome. With most infections, antiviral antibody will inhibit the initial binding step, and in so doing, will reduce viral infectivity. However, in certain cell-virus interactions, the presence of antiviral antibody increases infectivity, a phenomenon which is known as antibodydependent enhancement, or ADE, of viral infectivity [1][2][3][4].